This Plain Language Summary of Publication article (PLSP) from Postgraduate Medicine evaluated solriamfetol’s effects on people with obstructive sleep apnea who experienced excessive daytime sleepiness and cognitive impairment. Previous research showed solriamfetol improved wakefulness compared to placebo in these patients. This study specifically examined how the medication affected cognitive symptoms, using both objective cognitive performance tests and subjective ratings from participants about their cognitive function, impairment severity, and daytime sleepiness.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Results of the Solriamfetol’s Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP)’ and was published in the Chest.

Visit Chest Journal using the link to read the original article.